2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by RUBINGER, D. Articles by LURIA, M. H. Search for Related Content PubMed PubMed Citation Articles by RUBINGER, D. Articles by LURIA, M. H.

Heart Rate Variability during Chronic Hemodialysis and after Renal Transplantation

Studies in Patients without and with SystemicAmyloidosis

DVORA RUBINGER^*, DAN SAPOZNIKOV, ARTHUR POLLAK, MORDECAI M. POPOVTZER^* and MYRON H. LURIA

^* Nephrology and Hypertension Services, Hadassah University Hospital, Jerusalem, Israel.
Department of Cardiology, Hadassah University Hospital, Jerusalem, Israel.

Correspondence to Dr. Dvora Rubinger, Nephrology and Hypertension Services, Hadassah University Hospital, P. O. Box 12000, Jerusalem 91120, Israel. Phone: +972 2 6776881; Fax: +972 2 6427805; E-mail: henrietta{at}hadassah.org.il

Abstract

Abstract. The present study was undertaken to compare heart rate variability (HRV) values in patients on maintenance hemodialysis with no evidence of ischemic or hypertensive heart diseases to those of age- and gender-matched healthy individuals and those of patients after renal transplantation. To assess the effects of a common confounding factor, HRV values were also determined in patients with systemic amyloidosis, in chronic hemodialysis, and after successful renal transplantation. Spectral analyses of RR intervals from continuous electrocardiogram recordings were performed to quantify ultra low frequency, very low frequency, low frequency, and high frequency powers. HRV determinations were all significantly reduced in uremic patients undergoing hemodialysis compared with the healthy control subjects, especially in those with systemic amyloidosis. Renal transplantation normalized HRV in most patients; HRV, however, remained reduced in isolated amyloidosis patients with cardiac or adrenal involvement. HRV circadian day/night differences were preserved in hemodialysis patients and after renal transplantation in those without amyloidosis but not in those with amyloidosis. These data suggest that reduced HRV in chronic hemodialysis patients may precede other manifestations of cardiovascular disease. In uremic patients with amyloidosis, a more severe form of autonomic failure may occur. Successful transplantation corrects HRV abnormalities in most patients, suggesting that the autonomic dysfunction of uremia is caused by humoral factors reversed by the normalization of the renal function.

This article has been cited by other articles:

				D. Rubinger, N. Revis, A. Pollak, M. H. Luria, and D. Sapoznikov Predictors of haemodynamic instability and heart rate variability during haemodialysis Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2053 - 2060. [Abstract] [Full Text] [PDF]

				C. Kurata, A. Uehara, and A. Ishikawa Improvement of Cardiac Sympathetic Innervation by Renal Transplantation J. Nucl. Med., July 1, 2004; 45(7): 1114 - 1120. [Abstract] [Full Text] [PDF]

				H. Fukuta, J. Hayano, S. Ishihara, S. Sakata, S. Mukai, N. Ohte, K. Ojika, K. Yagi, H. Matsumoto, S. Sohmiya, et al. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis Nephrol. Dial. Transplant., February 1, 2003; 18(2): 318 - 325. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673